Zhengrong Chen: Children’s Hospital of Soochow University, China
Antonio Piralla: Fondazione IRCCS Policlinico San Matteo, Italy
Hassan Zaraket: Roche Products Ltd, United Kingdom
Submission Status: Open | Submission Deadline: 14 June 2024
BMC Infectious Diseases is calling for submissions to our Collection on Respiratory syncytial virus.
Respiratory syncytial virus (RSV) is a prevalent respiratory virus that can cause severe illness in people of all ages. The impact of the COVID-19 pandemic has led to a delayed RSV outbreak with a greater number of infected patients reported in numerous countries. Despite the high prevalence of RSV infections, there are currently limited treatment options and no effective vaccine. This highlights the urgency for continued efforts to better understand RSV and develop new strategies for its prevention and control. This collection invites submissions from researchers and practitioners in the field of RSV, including but not limited to epidemiology, surveillance, clinical management and diagnosis.